Robert Goldstein, MD
Plastic and Reconstructive Surgery · Yorktown Heights, NYNPI 1558475376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 45.0% of the total. 2025 is the largest year on record at $145, 3.1 times the $46 reported in 2020. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NY, where the typical reported total is $1,348.
Across 28 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$269
- Lilly USA, LLC$98
- Johnson & Johnson$44
- Mentor Worldwide LLC$36
- Merz North America, Inc.$32
- Kowa Pharmaceuticals America, Inc.$23
- plus $96 from 6 others
What the payments were for
- Food & beverage$57296%
- Education$254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 12 | $269 |
| Lilly USA, LLC | 4 | $98 |
| Johnson & Johnson | 2 | $44 |
| Mentor Worldwide LLC | 2 | $36 |
| Merz North America, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $18 |
| LEO Pharma Inc. | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
| AbbVie | 1 | $14 |
| Acelrx Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$597 in reported general payments places this provider in the 35th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 16 | $257 |
| Mupirocin | 28 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $54 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Yorktown Heights
- Thomas DavenportGarden City$2.8M
- Howard LangsteinRochester$350K
- James BradleyNew Hyde Park$306K
- David FuntWoodmere$295K
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Tara HustonStony Brook$95K
- Theodore DiktabanNew York$83K
- Jeffrey RidhaSaratoga Springs$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.